Central serous chorioretinopathy due to tadalafil use.
Phosphodiesterase-5 (PDE5) inhibitors are commonly used in the treatment of erectile dysfunction. There are a small number of case reports that associate this agent with central serous chorioretinopathy (CSCR). Our report presents the treatment approach to a 42-year-old patient who described blurred vision and metamorphopsia and was diagnosed with CSCR following the use of tadalafil, a PDE5 inhibitor.
Department of Ophthalmology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey. turkcufm@gmail.com
Fatih Mehmet
FM
Türkcü
Harun
H
Yüksel
Alparslan
A
Şahin
Mehmet
M
Murat
Yaşar
Y
Bozkurt
Ihsan
I
Çaça
D000328:Adult; D002243:Carbolines / Q000009:adverse effects*; D056833:Central Serous Chorioretinopathy / Q000139:chemically induced* / Q000473:pathology*; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000009:adverse effects*; D000068581:Tadalafil; D041623:Tomography, Optical Coherence
D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D000068581:Tadalafil